Based on advanced techniques of polymer chemistry, biotechnology, cell and tissue engineering, the application of innovative biomaterials will require new strategies for multidisciplinary research, involving academics and industrial partners.
Biomat-IN gathers 5 European clusters willing to pool their resources in order to foster innovation in the field of biomaterials through transnational cooperation: Eurasanté and Atlanpole Biotherapies in France, Bioregio Stern in Germany, Medilink EM in the UK and LIOF in the Netherlands.
Eurasanté - France
PROJECT LEADER BioRegio STERN - Germany Liof - The Netherlands
Eurasanté is an economic development agency focusing on healthcare, biotech and nutrition activities in Northern France (Lille / Nord Pas de Calais).
Eurasanté provides specific healthcare support for companies and project initiators in financial engineering, marketing, economic and strategic intelligence, regulatory affairs, technology transfer, training and networking events, international conference and exhibition support, etc.
Eurasanté is the project leader of the Biomat-IN project.
BioRegio STERN Management GmbH is an economic development organization for the biotechnology sector in the STERN region.
STERN stands for Stuttgart, Tübingen, Esslingen, Reutlingen and Neckar-Alb – five dynamic biotech sites comprising two regions in south-west Germany.
BioRegio STERN Management GmbH promotes biotech and medtech businesses by providing services to the SMEs, planning of events, and acquisition of funding and supporting business developments.
NV Industriebank LIOF is the Limburg development and investment company.
LIOF targets industry and the dynamic service sector, with special focus on Life Sciences, Chemistry & Materials, Agro/Food, and High Tech Systems.
Its four core activities are Acquisition, Participation, Development/Innovation and Business Parks, as these relate to the location/relocation of (foreign) companies, venture capital participation in Limburg companies with prospects, the development / implementation of programs and projects to sharpen the competitive edge of Limburg business and the coordination of the development of new business parks.
Atlanpole - France
MedilinkEM - United Kingdom
Atlanpole is the regional Technopole of the "Pays de la Loire" region (Western France).
Its core activities encompass business support and skills networking, project engineering for innovative individual or collaborative initiatives, as well as territorial and inward investment marketing.
The biocluster ATLANPOLE BIOTHERAPIES is focused on 4 main thematic areas including Cell and Gene therapy, Immunotherapy, Radiopharmaceuticals, Biomaterials and brings together SMEs, research laboratories and training centres located in the "Pays de la Loire" and neighbour regions.
Medilink East Midlands is the cluster organisation for the healthcare and bioscience sector in the “East Midlands” region (Central England), encompassing medical technologies, pharmaceuticals and biotechnology.
Medilink EM provides specific support in marketing, regulatory affairs, innovation, clinical evaluation,procurement, training and networking events, as well as international conference and exhibition support.
Medilink EM is also part of MedilinkUK - a coalition of independent organisations that cover the entire UK, and has a common mission to raise the profile of the medical and healthcare sectors in the UK.
next events
■ Euromedtech Grenoble 2012
EuroMedtech™ is the annual medical technology conference that provides collaboration opportunities to medtech CEOs, large corporation business development executives, investors and service providers.
The event features EBD Group’s partnering system, partneringONE®, the life science’s leading conference networking solution that enables delegates to mine a large pool of potential partners and pre-arrange private one-to-one meetings.
EuroMedtech also features 15-minute presentations of medical technology innovations by start-ups and established firms, panel discussions on industry developments and business development trends, and opportunities for informal networking.
We invite you to join us in Grenoble for Europe’s most intensely productive advanced medical technology event.
The Biomat-IN project has been selected to receive support from the European Regional Development Fund (ERDF) under the Interreg IVB North-West Europe call for projects. The official launch of the project will take place on March 18, 2011. Contact lenses, dental fillings, heart valves, or hip prostheses: the use of biomaterials, in the sense of biocompatible materials, is currently expanding to many medical applications and continues to grow. In direct connection with increased life expectancy and the demand for a better quality of life, the use of biomaterials is indeed rapidly increasing in the health sector. Relying on technical advances in polymer chemistry, biotechnology, gene therapy, and cell and tissue engineering, the development of innovative biomaterials will call for new multidisciplinary research strategies, involving public research entities and industrial players.
Biomat-IN was born from the desire of five European economic development actors to pool their resources to foster innovation in the field of biomaterials through transnational cooperation: Eurasanté and Atlanpole Biotherapies in France, Bioregio Stern in Germany, MedilinkEM in the United Kingdom, and LIOF in the Netherlands.
Biomat-IN has three main objectives:
Provide SMEs in the partner regions with key information to facilitate access to international markets.
The project will provide a transnational mapping of biomaterial sector actors and an online toolbox facilitating access to market, regulatory, and financial information.
Stimulate and facilitate transnational collaborations and partnerships within the biomaterials sector.
The project will list regional technological offers to accelerate technology transfer across the transnational area and will organize several B-To-B meetings as well as thematic think tanks.
Create a sustainable transnational support framework for SMEs in the implementation of their transnational R&D projects.
The project will set up a system of "service vouchers" to enable transnational R&D projects to benefit from feasibility studies.
Launched in March 2011, the project will last for three years. With a budget of 1.24 million euros, Biomat-IN will be half-funded by the European Regional Development Fund.
